Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3093

Actual shortage: 247 (8%)
Anticipated shortage: 14 (0%)
Avoided shortage: 9 (0%)
Resolved: 2823 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-DILTIAZ CD 180MG CAPSULE (CONTROLLED-DELIVERY) Resolved 2019-03-13 2019-07-12 78484
APO-DILTIAZ CD 180MG CAPSULE (CONTROLLED-DELIVERY) Resolved 2019-08-21 2019-10-15 92022
APO-MYCOPHENOLIC ACID 180MG TABLET (ENTERIC-COATED) Resolved 2019-10-09 2019-11-04 95871
APO-DEFERASIROX (TYPE J) 180MG TABLET Resolved 2020-03-18 2020-03-31 108927
APO-MYCOPHENOLIC ACID 180MG TABLET (ENTERIC-COATED) Resolved 2020-10-07 2021-01-26 125806
APO-DILTIAZ CD 180MG CAPSULE (CONTROLLED-DELIVERY) Resolved 2020-11-19 2020-11-27 128594
APO-DEFERASIROX (TYPE J) 180MG TABLET Resolved 2021-01-08 2021-01-20 131148
APO-DILTIAZ CD 180MG CAPSULE (CONTROLLED-DELIVERY) Resolved 2021-02-26 2021-08-23 134811
APO-MYCOPHENOLIC ACID 180MG TABLET (ENTERIC-COATED) Resolved 2021-06-18 2021-07-26 141247
APO-MYCOPHENOLIC ACID 180MG TABLET (ENTERIC-COATED) Resolved 2022-08-12 2023-01-13 166604
APO-ATOMOXETINE 18MG CAPSULE Resolved 2017-03-17 2017-07-17 3160
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2018-01-31 2018-05-05 37732
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2018-10-25 2018-11-22 65599
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2019-01-03 2019-05-17 71136
APO-HYDROMORPHONE CR 18MG CAPSULE (EXTENDED RELEASE) Resolved 2019-03-05 2020-04-04 77852
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2020-06-24 2020-08-17 118766
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2021-05-07 2021-09-20 138960
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2021-11-09 2022-01-06 148999
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2022-01-28 2022-03-24 153783
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2022-04-29 2022-12-17 159703

Showing 1001 to 1020 of 3093

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-DONEPEZIL 5MG TABLET Discontinued 2018-09-07 2019-02-13 60453
APO-ENALAPRIL 5MG TABLET Discontinued 2018-09-07 2018-11-02 60468
APO GLYBURIDE TAB 5MG 5MG TABLET Discontinued 2018-09-07 2018-12-14 60518
APO-LISINOPRIL 5MG TABLET Discontinued 2018-09-07 2019-02-13 60585
APO PREDNISONE TAB 5MG 5MG TABLET Discontinued 2018-09-08 2018-12-28 60699
APO-ROSUVASTATIN 5MG TABLET Discontinued 2018-09-08 2018-09-15 60775
APO-ALENDRONATE 5MG TABLET Discontinued 2019-01-03 2019-12-21 71023
BISACODYL 5MG TABLET (DELAYED-RELEASE) Discontinued 2019-01-03 2019-01-03 71090
APO-SOLIFENACIN 5MG TABLET Discontinued 2019-03-11 2019-09-20 78272
APO-PINDOL TAB 5MG 5MG TABLET Discontinued 2022-02-09 2022-02-10 154568
APO-CAPTO TAB 6.25MG 6.25MG TABLET Discontinued 2018-09-07 2019-06-12 60339
APO-CARVEDILOL 6.25MG TABLET To be discontinued 2024-01-26 2024-01-26 217499
APO-GEMFIBROZIL 600MG TABLET Discontinued 2017-03-31 2017-03-31 4927
APO-ATOMOXETINE 60MG CAPSULE Discontinued 2018-09-07 2018-09-15 60273
APO-BOSENTAN 62.5MG TABLET Discontinued 2019-01-04 2019-01-04 71339
APO-BROMAZEPAM 6MG TABLET Discontinued 2018-09-07 2018-10-19 60310
APO-HYDROMORPHONE CR 6MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110959
APO-MELOXICAM 7.5MG TABLET Discontinued 2018-09-07 2018-09-15 60612
APO-CIPROFLOX 750MG TABLET Discontinued 2018-09-07 2018-12-28 60388
APO-FENTANYL MATRIX 75MCG PATCH Discontinued 2018-09-07 2018-09-15 60497

Showing 321 to 340 of 356